DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines

Molecular Cancer

Volumn 7, Issue , 2008, Pages

  Roll, J Devon ^a   Rivenbark, Ashley G ^a   Jones, Wendell D ^b   Coleman, William B ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b Expression Analysis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; BISULFITE; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 1; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; UVOMORULIN; ANTINEOPLASTIC ANTIMETABOLITE; AZACITIDINE; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNMT3B PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CELL STRAIN MCF 7; CLUSTER ANALYSIS; CONTROLLED STUDY; DATA MINING; DNA METHYLATION; ENZYME ACTIVITY; EPITHELIUM CELL; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE SEGREGATION; GENE SEQUENCE; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PHENOTYPE; PROGNOSIS; PROMOTER REGION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; BREAST; BREAST TUMOR; CELL CULTURE; CPG ISLAND; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; TUMOR SUPPRESSOR GENE;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BREAST; BREAST NEOPLASMS; CPG ISLANDS; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; GENES, TUMOR SUPPRESSOR; HUMANS; PHENOTYPE; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED;

EID: 39649104991     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-7-15     Document Type: Article

References (66)

1. Laird PW Cancer epigenetics Hum Mol Genet 2005, 14(Spec No 1):R65-76 10.1093/hmg/ddi113 15809275
2. Baylin SB DNA methylation and gene silencing in cancer Nat Clin Pract Oncol 2005, 2(Suppl 1):S4-11 10.1038/ncponc0354 16341240
3. Hanahan D Weinberg RA The hallmarks of cancer Cell 2000, 100(1):57-70 10.1016/S0092-8674(00)81683-9 10647931
4. Toyota M Ahuja N Ohe-Toyota M Herman JG Baylin SB Issa JP CpG island methylator phenotype in colorectal cancer Proc Natl Acad Sci USA 1999, 96(15):8681-6 17576 10411935 10.1073/pnas.96.15.8681
5. Strathdee G Appleton K Illand M Millan DW Sargent J Paul J Brown R Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes Am J Pathol 2001, 158(3):1121-7 1850352 11238060
6. Liang G Salem CE Yu MC Nguyen HD Gonzales FA Nguyen TT Nichols PW Jones PA DNA methylation differences associated with tumor tissues identified by genome scanning analysis Genomics 1998, 53(3):260-8 10.1006/ geno.1998.5502 9799591
7. Toyota M Ahuja N Suzuki H Itoh F Ohe-Toyota M Imai K Baylin SB Issa JP Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype Cancer Res 1999, 59(21):5438-42 10554013
8. Shen L Ahuja N Shen Y Habib NA Toyota M Rashid A Issa JP DNA methylation and environmental exposures in human hepatocellular carcinoma J Natl Cancer Inst 2002, 94(10):755-61 12011226
9. Ueki T Toyota M Sohn T Yeo CJ Issa JP Hruban RH Goggins M Hypermethylation of multiple genes in pancreatic adenocarcinoma Cancer Res 2000, 60(7):1835-9 10766168
10. Eads CA Lord RV Kurumboor SK Wickramasinghe K Skinner ML Long TI Peters JH DeMeester TR Danenberg KD Danenberg PV Laird PW Skinner KA Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma Cancer Res 2000, 60(18):5021-6 11016622
11. Dulaimi E Ibanez de Caceres I Uzzo RG Al-Saleem T Greenberg RE Polascik TJ Babb JS Grizzle WE Cairns P Promoter hypermethylation profile of kidney cancer Clin Cancer Res 2004, 10(12 Pt 1):3972-9 10.1158/ 1078-0432.CCR-04-0175 15217927
12. Abe M Ohira M Kaneda A Yagi Y Yamamoto S Kitano Y Takato T Nakagawara A Ushijima T CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas Cancer Res 2005, 65(3):828-34 15705880
13. Melki JR Vincent PC Clark SJ Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia Cancer Res 1999, 59(15):3730-40 10446989
14. Kaneko Y Sakurai S Hironaka M Sato S Oguni S Sakuma Y Sato K Sugano K Saito K Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas Gut 2003, 52(5):641-6 1773639 12692046 10.1136/gut.52.5.641
15. Bae YK Brown A Garrett E Bornman D Fackler MJ Sukumar S Herman JG Gabrielson E Hypermethylation in histologically distinct classes of breast cancer Clin Cancer Res 2004, 10(18 Pt 1):5998-6005 10.1158/ 1078-0432.CCR-04-0667 15447983
16. Esteller M Dormant hypermethylated tumour suppressor genes: Questions and answers J Pathol 2005, 205(2):172-80 10.1002/path.1707 15643671
17. Fackler MJ McVeigh M Evron E Garrett E Mehrotra J Polyak K Sukumar S Argani P DNA methylation of RASSF1A, HIN-1, RAR-beta, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma Int J Cancer 2003, 107(6):970-5 10.1002/ijc.11508 14601057
18. Miyamoto K Fukutomi T Akashi-Tanaka S Hasegawa T Asahara T Sugimura T Ushijima T Identification of 20 genes aberrantly methylated in human breast cancers Int J Cancer 2005, 116(3):407-14 10.1002/ijc.21054 15818620
19. Parrella P Poeta ML Gallo AP Prencipe M Scintu M Apicella A Rossiello R Liguoro G Seripa D Gravina C Rabitti C Rinaldi M Nicol T Tommasi S Paradiso A Schittulli F Altomare V Fazio VM Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors Clin Cancer Res 2004, 10(16):5349-54 10.1158/ 1078-0432.CCR-04-0555 15328171
20. Melki JR Vincent PC Brown RD Clark SJ Hypermethylation of E-cadherin in leukemia Blood 2000, 95(10):3208-13 10807790
21. Haraguchi N Utsunomiya T Inoue H Tanaka F Mimori K Barnard GF Mori M Characterization of a side population of cancer cells from human gastrointestinal system Stem Cells 2006, 24(3):506-13 10.1634/ stemcells.2005-0282 16239320
22. Duxbury MS Ito H Benoit E Waseem T Ashley SW Whang EE A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells Cancer Res 2004, 64(11):3987-93 10.1158/0008-5472.CAN-04-0424 15173012
23. Keppler D Towards novel anti-cancer strategies based on cystatin function Cancer Lett 2006, 235(2):159-76 10.1016/j.canlet.2005.04.001 15893421
24. Rivenbark AG Jones WD Risher JD Coleman WB DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells Epigenetics 2006, 1(1):32-44 17998816
25. Ai L Kim WJ Kim TY Fields CR Massoll NA Robertson KD Brown KD Epigenetic Silencing of the Tumor Suppressor Cystatin M Occurs during Breast Cancer Progression Cancer Res 2006, 66(16):7899-7909 10.1158/ 0008-5472.CAN-06-0576 16912163
26. Hazan RB Qiao R Keren R Badano I Suyama K Cadherin switch in tumor progression Ann N Y Acad Sci 2004, 1014:155-63 10.1196/annals.1294.016 15153430
27. Madoz-Gurpide J Lopez-Serra P Martinez-Torrecuadrada JL Sanchez L Lombardia L Casal JI Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis Mol Cell Proteomics 2006, 5(8):1471-83 10.1074/mcp.M600048-MCP200 16733264
28. Stoesz SP Friedl A Haag JD Lindstrom MJ Clark GM Gould MN Heterogeneous expression of the lipocalin NGAL in primary breast cancers Int J Cancer 1998, 79(6):565-72 10.1002/ (SICI)1097-0215(19981218)79:6<565::AID-IJC3>3.0.CO;2-F 9842963
29. Bratt T Lipocalins and cancer Biochim Biophys Acta 2000, 1482(1-2):318-26 11058772
30. Girault I Tozlu S Lidereau R Bieche I Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas Clin Cancer Res 2003, 9(12):4415-22 14555514
31. Luczak MW Jagodzinski PP The role of DNA methylation in cancer development Folia Histochem Cytobiol 2006, 44(3):143-54 16977793
32. Van Rijnsoever M Elsaleh H Joseph D McCaul K Iacopetta B CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer Clin Cancer Res 2003, 9(8):2898-903 12912934
33. Frazier ML Xi L Zong J Viscofsky N Rashid A Wu EF Lynch PM Amos CI Issa JP Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer Cancer Res 2003, 63(16):4805-8 12941799
34. Toyota M Itoh F Imai K DNA methylation and gastrointestinal malignancies: Functional consequences and clinical implications J Gastroenterol 2000, 35(10):727-34 10.1007/s005350070030 11063215
35. Brock MV Gou M Akiyama Y Muller A Wu TT Montgomery E Deasel M Germonpre P Rubinson L Heitmiller RF Yang SC Forastiere AA Baylin SB Herman JG Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma Clin Cancer Res 2003, 9(8):2912-9 12912936
36. Roman-Gomez J Jimenez-Velasco A Agirre X Prosper F Heiniger A Torres A Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis J Clin Oncol 2005, 23(28):7043-9 10.1200/JCO.2005.01.4944 16192589
37. Giacinti L Claudio PP Lopez M Giordano A Epigenetic information and estrogen receptor alpha expression in breast cancer Oncologist 2006, 11(1):1-8 10.1634/theoncologist.11-1-1 16401708
38. Perou CM Sorlie T Eisen MB van de Rijn M Jeffrey SS Rees CA Pollack JR Ross DT Johnsen H Akslen LA Fluge O Pergamenschikov A Williams C Zhu SX Lonning PE Borresen-Dale AL Brown PO Botstein D Molecular portraits of human breast tumours Nature 2000, 406(6797):747-52 10.1038/35021093 10963602
39. Sorlie T Perou CM Tibshirani R Aas T Geisler S Johnsen H Hastie T Eisen MB van de Rijn M Jeffrey SS Thorsen T Quist H Matese JC Brown PO Botstein D Eystein Lonning P Borresen-Dale AL Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 2001, 98(19):10869-74 58566 11553815 10.1073/pnas.191367098
40. Livasy CA Karaca G Nanda R Tretiakova MS Olopade OI Moore DT Perou CM Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma Mod Pathol 2006, 19(2):264-71 10.1038/modpathol.3800528 16341146
41. Carey LA Perou CM Livasy CA Dressler LG Cowan D Conway K Karaca G Troester MA Tse CK Edmiston S Deming SL Geradts J Cheang MC Nielsen TO Moorman PG Earp HS Millikan RC Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study Jama 2006, 295(21):2492-502 10.1001/jama.295.21.2492 16757721
42. el-Deiry WS Nelkin BD Celano P Yen RW Falco JP Hamilton SR Baylin SB High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer Proc Natl Acad Sci USA 1991, 88(8):3470-4 51469 2014266 10.1073/pnas.88.8.3470
43. Eads CA Nickel AE Laird PW Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic Mice Cancer Res 2002, 62(5):1296-9 11888894
44. Belinsky SA Nikula KJ Baylin SB Issa JP Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer Proc Natl Acad Sci USA 1996, 93(9):4045-50 39484 8633014 10.1073/pnas.93.9.4045
45. Anzai H Frost P Abbruzzese JL Synergistic cytotoxicity with 2′-deoxy-5-azacytidine and topotecan in vitro and in vivo Cancer Res 1992, 52(8):2180-5 1373105
46. Ishiguro M Iida S Uetake H Morita S Makino H Kato K Takagi Y Enomoto M Sugihara K Effect of combined therapy with low-dose 5-aza-2′-deoxycytidine and irinotecan on colon cancer cell line HCT-15 Ann Surg Oncol 2007 14 5 1752 62 10.1245/s10434-006-9285-4 17195906
47. Arnold CN Goel A Boland CR Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines Int J Cancer 2003, 106(1):66-73 10.1002/ijc.11176 12794758
48. Paine TM Soule HD Pauley RJ Dawson PJ Characterization of epithelial phenotypes in mortal and immortal human breast cells Int J Cancer 1992, 50(3):463-73 10.1002/ijc.2910500323 1370949
49. ATCC http://www.atcc.org
50. Chomczynski P Sacchi N Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal Biochem 1987, 162(1):156-9 10.1016/0003-2697(87)90021-2 2440339
51. Suzuki H Gabrielson E Chen W Anbazhagan R van Engeland M Weijenberg MP Herman JG Baylin SB A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer Nat Genet 2002, 31(2):141-9 10.1038/ng892 11992124
52. Bender CM Pao MM Jones PA Inhibition of DNA methylation by 5-aza-2′-deoxycytidine suppresses the growth of human tumor cell lines Cancer Res 1998, 58(1):95-101 9426064
53. Grunau C Clark SJ Rosenthal A Bisulfite genomic sequencing: Systematic investigation of critical experimental parameters Nucleic Acids Res 2001, 29(13):E65-5 55789 11433041 10.1093/nar/29.13.e65
54. Primer3 Software http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi
55. National Center for Biotechnology Information http://www.ncbi.nih.gov
56. Yuecheng Y Hongmei L Xiaoyan X Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer Clin Exp Metastasis 2006, 23(1):65-74 10.1007/s10585-006-9020-3 16826427
57. Lapidus RG Nass SJ Butash KA Parl FF Weitzman SA Graff JG Herman JG Davidson NE Mapping of ER gene CpG island methylation-specific polymerase chain reaction Cancer Res 1998, 58(12):2515-9 9635570
58. Rivenbark AG Jones WD Coleman WB DNA methylation-dependent silencing of CST6 in human breast cancer cell lines Lab Invest 2006, 86(12):1233-42 10.1038/labinvest.3700485 17043665
59. Miyazaki T Murayama Y Shinomura Y Yamamoto T Watabe K Tsutsui S Kiyohara T Tamura S Hayashi N E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis Helicobacter 2007, 12(5):523-31 10.1111/j.1523-5378.2007.00519.x 17760721
60. UNC Microarray Database https://genome.unc.edu/pubsup/breastGEO
61. Weigelt B Hu Z He X Livasy C Carey LA Ewend MG Glas AM Perou CM Van't Veer LJ Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer Cancer Res 2005, 65(20):9155-8 10.1158/0008-5472.CAN-05-2553 16230372
62. Hu Z Fan C Oh DS Marron JS He X Qaqish BF Livasy C Carey LA Reynolds E Dressler L Nobel A Parker J Ewend MG Sawyer LR Wu J Liu Y Nanda R Tretiakova M Ruiz Orrico A Dreher D Palazzo JP Perreard L Nelson E Mone M Hansen H Mullins M Quackenbush JF Ellis MJ Olopade OI Bernard PS Perou CM The molecular portraits of breast tumors are conserved across microarray platforms BMC Genomics 2006, 7:96 1468408 16643655 10.1186/ 1471-2164-7-96
63. Oh DS Troester MA Usary J Hu Z He X Fan C Wu J Carey LA Perou CM Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers J Clin Oncol 2006, 24(11):1656-64 10.1200/ JCO.2005.03.2755 16505416
64. Perreard L Fan C Quackenbush JF Mullins M Gauthier NP Nelson E Mone M Hansen H Buys SS Rasmussen K Orrico AR Dreher D Walters R Parker J Hu Z He X Palazzo JP Olopade OI Szabo A Perou CM Bernard PS Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay Breast Cancer Res 2006, 8(2):R23 1557722 16626501 10.1186/bcr1399
65. VassarStats http://faculty.vassar.edu/lowry/rsig.html
66. Galen RS Statistics Gradwohl's Clinical Laboratory Methods and Diagnostics St. Louis: C.V. Mosby Sonnenwirth ACaJ L 8 1980:41-68